Biochanin A overcomes gemcitabine resistance in pancreatic cancer cells

被引：0
|
作者：
Bhardwaj, Vikas [1 ]
Lai, James C. K. [1 ]
Bhushan, Alok [1 ]
机构：
[1] Idaho State Univ, Pocatello, ID 83209 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-1747
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1747
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Effect of acquisition of gemcitabine resistance on intracellular metabolism in pancreatic cancer cells
    Yamakawa, Keiko
    Ye, Juanjuan
    Mukai, Yuri
    Okano, Keiichi
    Suizu, Futoshi
    Kadota, Kyuichi
    CANCER SCIENCE, 2025, 116 : 690 - 690
  • [12] Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt
    Bartholomeusz, Chandra
    Yamasaki, Fumiyuki
    Saso, Hitomi
    Kurisu, Kaoru
    Hortobagyi, Gabriel N.
    Ueno, Naoto T.
    JOURNAL OF CANCER, 2011, 2 : 435 - 442
  • [13] A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistance
    Hee Seung Lee
    Soo Been Park
    Sun A Kim
    Sool Ki Kwon
    Hyunju Cha
    Do Young Lee
    Seonggu Ro
    Joong Myung Cho
    Si Young Song
    Scientific Reports, 7
  • [14] A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistance
    Lee, Hee Seung
    Park, Soo Been
    Kim, Sun A.
    Kwon, Sool Ki
    Cha, Hyunju
    Lee, Do Young
    Ro, Seonggu
    Cho, Joong Myung
    Song, Si Young
    SCIENTIFIC REPORTS, 2017, 7
  • [15] USP44 suppresses pancreatic cancer progression and overcomes gemcitabine resistance by deubiquitinating FBP1
    Yang, Chong
    Zhu, Shikai
    Yang, Hongji
    Deng, Sisi
    Fan, Ping
    Li, Mi
    Jin, Xin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (08): : 1722 - 1733
  • [16] The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer
    Hage, C.
    Rausch, V.
    Giese, N.
    Giese, T.
    Schoensiegel, F.
    Labsch, S.
    Nwaeburu, C.
    Mattern, J.
    Gladkich, J.
    Herr, I.
    CELL DEATH & DISEASE, 2013, 4 : e627 - e627
  • [17] The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer
    C Hage
    V Rausch
    N Giese
    T Giese
    F Schönsiegel
    S Labsch
    C Nwaeburu
    J Mattern
    J Gladkich
    I Herr
    Cell Death & Disease, 2013, 4 : e627 - e627
  • [18] CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells
    Hong, Sung Pil
    Wen, Jing
    Bang, Seungmin
    Park, Seungwoo
    Song, Si Young
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (10) : 2323 - 2331
  • [19] NUC-1031 overcomes resistance associated with gemcitabine in cancer patients
    Bre, Jennifer
    Sarr, Awa
    Mullen, Peter
    Um, In Hwa
    Blagden, Sarah P.
    Reynolds, Paul A.
    Harrison, David J.
    CANCER RESEARCH, 2018, 78 (13)
  • [20] Targeting Pancreatic Cancer by EGCG in Gemcitabine Resistance
    Ghosh, C.
    Paul, S.
    Anant, S.
    Dhar, A.
    PANCREAS, 2016, 45 (10) : 1507 - 1507
12345